InvestorsHub Logo
Followers 0
Posts 42
Boards Moderated 0
Alias Born 03/22/2017

Re: gr8db8 post# 920

Tuesday, 05/16/2017 7:44:15 PM

Tuesday, May 16, 2017 7:44:15 PM

Post# of 2099
7) Not doing ph3 for thyroid but said that if VB-111 is on the market and thyroid patients need the drug then it could be available for them without a need to do a full ph3 for thyroid. Nice to cross that bridge when that happens.

Question: Can VBLT do the same thing mentioned above to the Ovarian without phase 3 trial ? and why would vblt declined the SPA that wad offered to them by the FDA?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News